missing translation for 'onlineSavingsMsg'
Learn More
Learn More
DUSP1 Monoclonal Antibody (OTI4F10), TrueMAB™, OriGene
Mouse Monoclonal Antibody
Brand: Origene Technologies TA812680S
This item is not returnable.
View return policy
Description
DUSP1 Monoclonal antibody specifically detects DUSP1 in Human samples. It is validated for Western BlotSpecifications
| DUSP1 | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
| P25942 | |
| Mouse | |
| Affinity chromatography | |
| RUO | |
| 958 | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| IgG1 |
| Western Blot | |
| OTI4F10 | |
| Unconjugated | |
| CD40 | |
| 3ch134; 3CH134/CL100 PTPase; CL 100; CL100; dual specificity phosphatase 1; dual specificity protein phosphatase 1; Dual specificity protein phosphatase hVH1; DUS1; DUSP1; EC 3.1.3.16; EC 3.1.3.48; erp; HVH1; MAP kinase phosphatase 1; MAP kinase phosphatase-1; mitogen-activated protein (MAP) kinase phosphatase-1; mitogen-activated protein kinase phosphatase 1; mitogen-activated protein kinase phosphatase-1; MKP1; mkp-1; oxidative stress-inducible protein tyrosine phosphatase; protein tyrosine phosphatase non-receptor type 16; protein tyrosine phosphatase, non-receptor type 16; protein-tyrosine phosphatase 3CH134; Protein-tyrosine phosphatase CL100; protein-tyrosine phosphatase ERP; Protein-tyrosine phosphatase non-receptor type 16; PTPN10; Ptpn16; serine/threonine specific protein phosphatase; U19515; VH1 | |
| Human recombinant protein fragment corresponding to amino acids 21-193+Mouse Fc of human CD40 (NP_001241) produced in 293E cell. | |
| 30 μL | |
| Primary | |
| Human | |
| Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction